Expert perspectives on hot topics in rheumatology. Join world leading experts as they discuss the cutting-edge research influencing your clinical practice.
2nd February 2023
- Maya Buch (Chair)
- Anja Strangfeld: Long term safety data and FDA labelling for JAKi in RA
- Chris Edwards: European PRAC review of JAKi data
- Lorenzo Dagna: Key considerations from a clinical perspective
11th January 2023
- Iain McInnes- Chair
- Janet Pope - A Year in Review: RA
- Philip Mease - A Year in Review: PsA
- Xenofon Baraliakos - A Year in Review: AxSpA
7th December 2022
- Rieke Alten (Chair)
- Eugen Feist (Treatment Considerations in RA Patients with Special Considerations: Cardiovascular and Renal Disease)
- Peter Taylor (Considerations When Treating Women of a Childbearing Age in Inflammatory Arthritis)
21st November 2022
With the continued release of new treatment data in RA, axSpA, and PsA, this webinar will highlight the key data presented at ACR 2022. This session will review the latest safety and efficacy data of JAK inhibitors as well as the impact on clinical practice and patient outcomes. Join us and get your cytokine signalling updates from ACR 2022.
- Leonard Calabrese (Chair): RA: A Therapeutic Update
- Laura Coates: The Modern World of PsA Treatment
- Sofia Ramiro: The Latest Advances in axSpA
4th November 2022
- Maya Buch (Chair)
- Anja Strangfeld: Latest understandings of JAKinib safety
- Chris Edwards: EULAR 2022 Recommendations update
- Lorenzo Dagna: Key considerations from a clinical perspective
2nd November 2022
- John Isaacs (Chair)
- Edward Vital: The Bruton’s Tyrosine Kinase pathway – an attractive target in autoimmune disease?
- David Isenberg: Targeting the BTK pathway in SLE
- Stanley Cohen: Targeting the BTK pathway in RA
